EMG
SRNE

ETF Managers Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

ETF Managers Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-117,646
Closed -$104K – 757
2022
Q4 		$104K Sell
117,646
-15,132
-11% -$20.1K ﹤0.01% 490
2022
Q3 		$208K Buy
132,778
+9,896
+8% +$22.4K 0.01% 594
2022
Q2 		$245K Buy
122,882
+27,465
+29% +$47.5K 0.01% 625
2022
Q1 		$226K Buy
95,417
+2,391
+3% +$7.46K ﹤0.01% 596
2021
Q4 		$456K Buy
+93,026
New +$578K 0.01% 530
2021
Q2 		– Sell
-1,092
Closed -$9K – 815
2021
Q1 		$9K Sell
1,092
-115,329
-99% -$1.22M ﹤0.01% 660
2020
Q4 		$842K Buy
116,421
+24,884
+27% +$200K 0.02% 255
2020
Q3 		$1.06M Buy
91,537
+23,999
+36% +$220K 0.03% 200
2020
Q2 		$413K Buy
+67,538
New +$259K 0.01% 291

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

ETF Managers Group's SRNE Position: Q1 2023 in Review

ETF Managers Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 117,646 shares — an estimated $104K sold.

ETF Managers Group first reported a position in SRNE in Q2 2020 and held it in 9 quarters. The position peaked at $1.06M in Q3 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • ETF Managers Group reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • ETF Managers Group sold 117,646 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $104K.
  • ETF Managers Group first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and held it in 9 quarters.
  • ETF Managers Group's Sorrento Therapeutics, Inc. position peaked at $1.06M in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.